Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice. 1988

D C Rees, and R L Balster
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond.

The imidazobenzodiazepine Ro 15-4513 has a high affinity for central benzodiazepine binding sites and has been shown to antagonize certain effects of ethanol. The purpose of the present study was to determine if Ro 15-4513 would attenuate the discriminative stimulus properties of ethanol and the other central nervous system depressants pentobarbital and oxazepam. Different groups of mice were trained to discriminate 1.0 or 1.5 g/kg of ethanol, 20 mg/kg of pentobarbital or 10 mg/kg of oxazepam from saline injections in a two-lever operant task. Stimulus generalization tests were conducted with Ro 15-4513 alone (0.01-20 mg/kg) and in combination with the training drugs. The discriminative stimulus effects of ethanol and oxazepam, but not of pentobarbital, were blocked by Ro 15-4513. When given alone in each of the different drug-training groups, Ro 15-4513 did not produce drug-lever responding but decreased overall response rates in a dose-related fashion. Although the alcohols, barbiturates and benzodiazepines share discriminative stimulus properties under many conditions, the selective blockade of their stimulus effects provides further evidence that their actions may be mediated by different cellular mechanisms. These data also show that Ro 15-4513 may attenuate behavioral effects of ethanol relevant to its abuse.

UI MeSH Term Description Entries
D008297 Male Males
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D004193 Discrimination Learning Learning that is manifested in the ability to respond differentially to various stimuli. Discriminative Learning,Discrimination Learnings,Discriminative Learnings,Learning, Discrimination,Learning, Discriminative
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005795 Generalization, Stimulus The tendency to react to stimuli that are different from, but somewhat similar to, the stimulus used as a conditioned stimulus. Generalizations, Stimulus,Stimulus Generalization,Stimulus Generalizations
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide

Related Publications

D C Rees, and R L Balster
January 1989, Behavioural pharmacology,
D C Rees, and R L Balster
May 1990, European journal of pharmacology,
D C Rees, and R L Balster
November 1996, Pharmacology, biochemistry, and behavior,
D C Rees, and R L Balster
January 1989, Alcohol (Fayetteville, N.Y.),
D C Rees, and R L Balster
September 1987, Pharmacology, biochemistry, and behavior,
D C Rees, and R L Balster
November 1989, Pharmacology, biochemistry, and behavior,
D C Rees, and R L Balster
January 1989, European journal of pharmacology,
Copied contents to your clipboard!